The Real Reason Pot Stocks Have Plunged

The cannabis sector is slumping because the industry giants, Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) and Canopy Growth Corp (TSX:WEED)(NYSE:CGC), are both struggling with different issues.

| More on:
Businessman looking at a red arrow crashing through the floor

Image source: Getty Images.

If the scandals and controversies in the marijuana industry aren’t enough, the shares of the two largest cannabis companies are plummeting. If the downtrend continues, will the entire industry collapse?

In the last two months, Canopy (TSX:WEED)(NYSE:CGC) has fallen by 38%. Aurora (TSX:ACB)(NYSE:ACB) has dropped by 24%. The industry giants are losing steam, while investors’ interest is clearly fading.

Ruptured image

Canopy was supposed to be the prime weed stock following the partnership with American beverage giant Constellation Brands. But things got ugly in July. Bruce Linton, the company’s co-founder, was kicked out. The principal investor didn’t like the mounting losses and excessive spending by the long-time CEO.

The fiscal first-quarter 2020 results for the period ended June 30, 2019, presented in mid-August, revealed the truth. Canopy lost $1.28 billion coming from a $91 million loss in fiscal Q1 2019. And the backlash is continuing for the headless cannabis company.

Canopy is in a bind. The sizable loss brought down the company’s market capitalization, which stands at $11.5 billion to date. If the pace of expenditures doesn’t slow down, Canopy’s treasure chest might dry out sooner rather than later. The M&A activities accounted for 59% of the enormous losses.

Rumours are circulating that Bruce Linton is buying shares of Canopy or recommending a buy rating. Whether there’s truth to it or not, Canopy projects revenue to rise by 185.5% to 646.3 million in fiscal 2020 and by 87.1% to $1.21 billion in fiscal 2021.

The company’s expected net loss in fiscal 2020 is $1.38 billion in fiscal 2020 but is projected to drop to $310.7 million in fiscal 2021. For WEED, invest at your own risk.

Far from profitability

Aurora is in a precarious situation as well. The acknowledged leader in cannabis production is still too distant to be profitable. This $7.63 billion marijuana company reported a net loss of $158.4 million in the quarter ending March 31, 2019.

During the most recent conference call, Cam Battley, Aurora’s chief corporate officer, was quick to say that the company is on a “pathway to profitability.” But more likely, Aurora will realize substantial profits no sooner than its fiscal 2021 or by June 30, 2021.

The question now is whether Aurora needs a moneyed institutional partner moving forward. Strategic advisor Nelson Peltz warns against yielding majority ownership to a prominent investor. Aurora is not keen on working out a deal with any, at least not yet.

The latest development for Aurora is the push into the hemp market. The company confirmed completing its acquisition of all outstanding shares of Hempco Food and Fiber. The transaction is worth $63.4 million.

Risky investments

Investors in the cannabis space are exhausted. They’re having difficulty evaluating weed stocks.

Constellation Brands might decide to take a super-majority stake in Canopy Growth as it continues the search for a new leader.

Meanwhile, Aurora Cannabis is not selling out, nor it is ready to jump into edible marijuana and cannabis-infused beverages. But with the way things are going, weed stocks are risky investments.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »